Immunotherapy in asthma: an updated systematic review
暂无分享,去创建一个
[1] L. Jäger. The future of immunotherapy , 1999, Allergy.
[2] M. Adachi,et al. Effect of rush immunotherapy on airway inflammation and airway hyperresponsiveness after bronchoprovocation with allergen in asthma. , 1998, The Journal of allergy and clinical immunology.
[3] M. Adachi,et al. Long-term analysis of allergen-specific T cell clones from patients with asthma treated with allergen rush immunotherapy. , 1998, Cellular immunology.
[4] A D Oxman,et al. The unpredictability paradox: review of empirical comparisons of randomised and non-randomised clinical trials , 1998, BMJ.
[5] H. Matsuo,et al. Effect of Immunotherapy on the Production of Eosinophil Adhesion-Inducing Activity from Mononuclear Cells in House-Dust-Mite-Sensitive Bronchial Asthma , 1998, International Archives of Allergy and Immunology.
[6] Stevens,et al. Comparison between the in vitro cytokine production of mononuclear cells of young asthmatics with and without immunotherapy (IT) , 1998, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[7] P. Papageorgiou,et al. Double‐blind, placebo‐controlled evaluation of sublingual immunotherapy with standardized olive pollen extract in pediatric patients with allergic rhinoconjunctivitis and mild asthma due to olive pollen sensitization , 1998, Allergy.
[8] Giorgio Walter Canonica,et al. Allergen immunotherapy: therapeutic vaccines for allergic diseases , 1998 .
[9] J. Bousquet,et al. Immunotherapy vs inhaled budesonide in bronchial asthma: an open, parallel comparative trial , 1998, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[10] K. Takagi,et al. Computed tomographic findings in non‐specific interstitial pneumonia/fibrosis , 1998, Respirology.
[11] J. Bousquet,et al. Clinical efficacy of sublingual‐swallow immunotherapy: a double‐blind, olacebo‐controlled trial of a standardized five‐grass‐pollen extract in rhinitis , 1998, Allergy.
[12] B. Chiang,et al. Immunologic changes during immunotherapy in asthmatic children: increased IL-13 and allergen-specific IgG4 antibody levels. , 1998, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.
[13] L. Elfman,et al. Allergen‐Specific increase in interleukin (IL)‐4 and IL‐5 secretion from peripheral blood mononuclear cells during birch‐pollen immunotherapy , 1998, Allergy.
[14] O. Kalayci,et al. The effect of house dust mite specific immunotherapy on cysteinyl leukotriene production by blood leukocytes in subjects with perennial allergic rhinitis and asthma. , 1998, Journal of investigational allergology & clinical immunology.
[15] G. Canonica,et al. Randomised controlled trial of local allergoid immunotherapy on allergic inflammation in mite-induced rhinoconjunctivitis , 1998, The Lancet.
[16] U. Wahn,et al. The combined influence of immunotherapy and mite allergen reduction on bronchial hyperresponsiveness in mite-sensitive asthmatic children , 1998, European Journal of Pediatrics.
[17] S. Petrović,et al. Early effects of rush immunotherapy with Dermatophagoides pteronyssinus in asthmatics. , 1997, Journal of investigational allergology & clinical immunology.
[18] J. Ioannidis,et al. Quantitative Synthesis in Systematic Reviews , 1997, Annals of Internal Medicine.
[19] S. Martín,et al. Clinical efficacy and tolerance of two year Lolium perenne sublingual immunotherapy. , 1997, Allergologia et immunopathologia.
[20] E. Valovirta. Capacity of specific immunotherapy in prevention of allergic asthma in children: the Preventive Allergy Treatment Study (PAT). , 1997, Journal of investigational allergology & clinical immunology.
[21] K. Larsen,et al. A 1‐year, placebo‐controlled, double‐blind house‐dust‐mite immunotherapy study in asthmatic adults , 1997, Allergy.
[22] A. Frew,et al. Clinical efficacy of specific immunotherapy to cat dander: a double‐blind placebo‐controlled trial , 1997, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[23] J. Bousquet,et al. Immunotherapy with a standardized Dermatophagoides pteronyssinus extract. VI. Specific immunotherapy prevents the onset of new sensitizations in children. , 1997, The Journal of allergy and clinical immunology.
[24] W. Pichler,et al. Specific immunotherapy with Dermatophagoides pteronyssinus and D. farinae results in decreased bronchial hyperreactivity , 1997, Allergy.
[25] J. Tonascia,et al. A controlled trial of immunotherapy for asthma in allergic children. , 1997, The New England journal of medicine.
[26] F. Simons,et al. Fel d 1 peptides: effect on skin tests and cytokine synthesis in cat-allergic human subjects. , 1996, International immunology.
[27] E. Iemoli,et al. Sublingual versus injective immunotherapy in grass pollen allergic patients: a double blind (double dummy) study , 1996, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[28] I. Olkin,et al. Improving the quality of reporting of randomized controlled trials. The CONSORT statement. , 1996, JAMA.
[29] A. Franzese,et al. Effects of enzyme-potentiated desensitization in the treatment of pollinosis: a double-blind placebo-controlled trial. , 1996, Journal of investigational allergology & clinical immunology.
[30] C. Martínez-Cócera,et al. A double‐blind, placebo‐controlled study of immunotherapy with grass‐pollen extract Alutard SQ during a 3–year period with initial rush immunotherapy , 1996, Allergy.
[31] A. Cantani,et al. Enzyme-potentiated desensitization in children with asthma and mite allergy: a double-blind study. , 1996, Journal of investigational allergology & clinical immunology.
[32] D. Bernstein,et al. Evaluation of household dust mite exposure and levels of specific IgE and IgG antibodies in asthmatic patients enrolled in a trial of immunotherapy. , 1996, The Journal of allergy and clinical immunology.
[33] L. Delgado,et al. Effects of immunotherapy on symptoms, PEFR, spirometry, and airway responsiveness in patients with allergic asthma to house‐dust mites (D. pteronyssinus) on inhaled steroid therapy , 1996, Allergy.
[34] A R Jadad,et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? , 1996, Controlled clinical trials.
[35] G. Hedlin,et al. Long-term follow-up of patients treated with a three-year course of cat or dog immunotherapy. , 1995, The Journal of allergy and clinical immunology.
[36] R. Lockey. Adverse reactions associated with skin testing and immunotherapy. , 1995, Allergy proceedings : the official journal of regional and state allergy societies.
[37] T. Lobera,et al. Immunotherapy with a standardized Dermatophagoides pteronyssinus glutaraldehyde-modified extract against an unmodified extract: a comparative study of efficacy, tolerance and in vivo and in vitro modification of parameters. , 1995, Journal of investigational allergology & clinical immunology.
[38] G. Senna,et al. Local nasal immunotherapy for birch allergic rhinitis with extract in powder form , 1995, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[39] P. Ventas,et al. Immunotherapy with the storage mite lepidoglyphus destructor. , 1995, Allergologia et immunopathologia.
[40] V. Feliziani,et al. Safety and efficacy of sublingual rush immunotherapy with grass allergen extracts. A double blind study. , 1995, Allergologia et immunopathologia.
[41] R. Puy,et al. Is allergen immunotherapy effective in asthma? A meta-analysis of randomized controlled trials. , 1995, American journal of respiratory and critical care medicine.
[42] C. Franco,et al. A double-blind, placebo controlled study of Alpare mite D. pteronyssinus immunotherapy in asthmatic patients. , 1995, Allergologia et immunopathologia.
[43] M. Cazzola,et al. Immunotherapy with Alpare® in patients with respiratory allergy to Parietaria pollen: a two year double‐blind placebo‐controlled study , 1995, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[44] A. Valero,et al. Clinical and immunological effects of immunotherapy with glutaraldehyde modified house dust mite extract. , 1994, Allergologia et immunopathologia.
[45] A. Moreira,et al. [Topical nasal immunotherapy with Dermatophagoides pteronyssinus extract]. , 1994, Allergologia et immunopathologia.
[46] J. Cuesta-Herranz,et al. Monoclonal antibody-standardized cat extract immunotherapy: risk-benefit effects from a double-blind placebo study. , 1994, The Journal of allergy and clinical immunology.
[47] G. Passalacqua,et al. A three‐year double‐blind placebo‐controlled study with specific oral immunotherapy to Dermatophagoides: evidence of safety and efficacy in paediatric patients , 1994, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[48] J. C. Trindade,et al. Specific immunotherapy 3 years follow-up in asthmatic children. , 1993, Allergologia et immunopathologia.
[49] Y. Yanagihara,et al. Effect of rush immunotherapy in house-dust-mite (HDM)-sensitive adult bronchial asthma: changes in in vivo and in vitro responses to HDM. , 1993, Internal medicine.
[50] A. Scheynius,et al. The effect of immunotherapy on T‐cell subsets in peripheral blood and bronchoalveolar lavage fluid in pollen‐allergic patients , 1993, Allergy.
[51] L. Férnandez de Corres,et al. Seasonal versus perennial immunotherapy: evaluation after three years of treatment. , 1993, Journal of investigational allergology & clinical immunology.
[52] J. Saint-Remy,et al. Significant reduction of nonspecific bronchial reactivity in patients with Dermatophagoides pteronyssinus-sensitive allergic asthma under therapy with allergen-antibody complexes. , 1993, The American review of respiratory disease.
[53] M. Nagata,et al. [The analysis of factors contributing to the safety and efficacy of rush immunotherapy in bronchial asthma]. , 1993, Arerugi = [Allergy].
[54] S. Rak. Effects of immunotherapy on the inflammation in pollen asthma , 1993, Allergy.
[55] R. Dahl,et al. A controlled dose-response study of immunotherapy with standardized, partially purified extract of house dust mite: clinical efficacy and side effects. , 1993, The Journal of allergy and clinical immunology.
[56] J. Bousquet,et al. Modulation of eicosanoid and histamine release from human dispersed lung cells by terfenadine , 1993, Allergy.
[57] G. Salcedo,et al. Evaluation of immune complexes after immunotherapy with wheat flour in bakers' asthma. , 1992, Annals of allergy.
[58] R. Dahl,et al. Immunotherapy in patients allergic to cat and dog dander , 1992, Allergy.
[59] H. Van Bever,et al. Effect of hyposensitization upon the immediate and late asthmatic reaction and upon histamine reactivity in patients allergic to house dust mite (Dermatophagoides pteronyssinus). , 1992, The European respiratory journal.
[60] L. Corbetta,et al. Improvement of fog and exercise-induced bronchoconstriction after local and subcutaneous immunotherapy in mite asthma. , 1992, Allergologia et immunopathologia.
[61] M. Mancino,et al. Immunotherapy by inhalation of allergen in powder in house dust allergic asthma--a double-blind study. , 1992, Journal of investigational allergology & clinical immunology.
[62] W. Metzger,et al. IMMUNOTHERAPY WITH POLLENS AND FUNGI , 1992, Immunology and Allergy Clinics of North America.
[63] G. Moscato,et al. Local immunotherapy by inhalation of a powder extract in asthma due to house dust mite Dermatophagoides pteronyssinus: a double-blind comparison with parenteral immunotherapy. , 1991, Journal of investigational allergology & clinical immunology.
[64] J. Saint-Remy,et al. Allergen‐antibody complexes can efficiently prevent seasonal rhinitis and asthma in grass pollen, hypersensitive patients , 1991, Allergy.
[65] J. Bousquet,et al. Differences in clinical and immunologic reactivity of patients allergic to grass pollens and to multiple-pollen species. II. Efficacy of a double-blind, placebo-controlled, specific immunotherapy with standardized extracts. , 1991, The Journal of allergy and clinical immunology.
[66] G. Hedlin,et al. Immunotherapy with cat- and dog-dander extracts , 1991 .
[67] V. Brusasco,et al. Local immunotherapy with Dermatophagoides extract in asthma. , 1991, The Journal of allergy and clinical immunology.
[68] A. Sabbah,et al. [Specific immunotherapy using Alpha-Fraction-Retard-D. pteronyssinus. Double-blind study in asthma]. , 1991, Allergie et immunologie.
[69] P. Venge,et al. Immunotherapy abrogates the generation of eosinophil and neutrophil chemotactic activity during pollen season. , 1990, The Journal of allergy and clinical immunology.
[70] M. Jacquemin,et al. Complexes of grass pollen allergens and specific antibodies reduce allergic symptoms and inhibit the seasonal increase of IgE antibody , 1990, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[71] M. Mancino,et al. Efficacy of sublingual immunotherapy in patients with rhinitis and asthma due to house dust mite. A double-blind study. , 1990, Allergologia et immunopathologia.
[72] K. Shimanuki,et al. [Long-term follow up studies of bronchial asthma in children. II. Prognosis and complications, treatment and allergic evaluations]. , 1990, Arerugi = [Allergy].
[73] H. Van Bever,et al. Evolution of the late asthmatic reaction during immunotherapy and after stopping immunotherapy. , 1990, The Journal of allergy and clinical immunology.
[74] J. Bousquet,et al. Comparison between RAST and Pharmacia CAP system: a new automated specific IgE assay. , 1990, The Journal of allergy and clinical immunology.
[75] P. Sly,et al. Childhood asthma: Application of the international view of management in Australia and New Zealand * , 1990 .
[76] S. Lebecque,et al. Allergic bronchial asthma due to Dermatophagoides pteronyssinus hypersensitivity can be efficiently treated by inoculation of allergen-antibody complexes. , 1990, The Journal of clinical investigation.
[77] H. Mosbech. Who will benefit from hyposensitization? , 1990, Allergy.
[78] Malling Hj. Diagnosis and immunotherapy of mould allergy. With special reference to Cladosporium herbarum. , 1990 .
[79] J. Bousquet,et al. Double-blind, placebo-controlled immunotherapy with mixed grass-pollen allergoids. IV. Comparison of the safety and efficacy of two dosages of a high-molecular-weight allergoid. , 1990, The Journal of allergy and clinical immunology.
[80] J. Bousquet,et al. Double-blind, placebo-controlled rush immunotherapy with a standardized Alternaria extract. , 1990, The Journal of allergy and clinical immunology.
[81] A. SánchezPalacios,et al. Comparative clinical-immunological study of oral and subcutaneous immunotherapy in children with extrinsic bronchial asthma. , 1989 .
[82] J. Bousquet,et al. Double-blind, placebo-controlled immunotherapy with mixed grass-pollen allergoids. III. Efficacy and safety of unfractionated and high-molecular-weight preparations in rhinoconjunctivitis and asthma. , 1989, The Journal of allergy and clinical immunology.
[83] H. Mosbech,et al. Hyposensitization in asthmatics with mPEG modified and unmodified house dust mite extract , 1989, Allergy.
[84] X. Baur. [Hyposensitization in bronchial asthma--still a current therapeutic procedure?]. , 1989, Medizinische Klinik.
[85] H. Mosbech,et al. Hyposensitization in asthmatics with mPEG modified and unmodified house dust mite extract , 1989, Allergy.
[86] A. Blanco‐quirós,et al. Rush immunotherapy with a standardized Bermuda grass pollen extract. , 1989, Annals of allergy.
[87] T. Kristensen,et al. Immunotherapy with dog and cat extracts in children , 1989, Allergy.
[88] W. Stevens,et al. Suppression of the late asthmatic reaction by hyposensitization in asthmatic children allergic to house dust mite (Dermatophagoides pteronyssinus) , 1989, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[89] P. Kuna,et al. The effect of preseasonal immunotherapy on the production of histamine-releasing factor (HRF) by mononuclear cells from patients with seasonal asthma: results of a double-blind, placebo-controlled, randomized study. , 1989, The Journal of allergy and clinical immunology.
[90] J. Hałuszka,et al. [Results of immunotherapy with HDM (Bencard) in children with bronchial asthma]. , 1989, Pediatria polska.
[91] E. Pastorello,et al. A double‐blind study of hyposensitization with an alginate conjugated extract of D. pteronyssinus (Conjuvac®) in patients with perennial rhinitis , 1989 .
[92] A. Kagey‐Sobotka,et al. Immunotherapy for cat asthma. , 1988, The Journal of allergy and clinical immunology.
[93] J. Bousquet,et al. Specific immunotherapy with a standardized Dermatophagoides pteronyssinus extract. II. Prediction of efficacy of immunotherapy. , 1988, The Journal of allergy and clinical immunology.
[94] P. Venge,et al. The effect of immunotherapy on bronchial hyperresponsiveness and eosinophil cationic protein in pollen-allergic patients. , 1988, The Journal of allergy and clinical immunology.
[95] U. Wahn,et al. Prospective study on immunologic changes induced by two different Dermatophagoides pteronyssinus extracts prepared from whole mite culture and mite bodies. , 1988, The Journal of allergy and clinical immunology.
[96] H. Chai,et al. Cat- or dog-induced immediate and late asthmatic responses before and after immunotherapy. , 1988, The Journal of allergy and clinical immunology.
[97] J. Bousquet,et al. Double-blind, placebo-controlled immunotherapy with mixed grass-pollen allergoids. II. Comparison between parameters assessing the efficacy of immunotherapy. , 1988, The Journal of allergy and clinical immunology.
[98] W. Stevens,et al. Modification of the late asthmatic reaction by hyposensitization in asthmatic children allergic to house dust mite (Dermatophagoides pteronyssinus) or grass pollen , 1988, Allergy.
[99] H. Ipsen,et al. Immunotherapy with partially purified and standardized tree pollen extracts , 1988, Allergy.
[100] B. Björkstén,et al. Oral immunotherapy in birch pollen hay fever. , 1987, The Journal of allergy and clinical immunology.
[101] R. Moss,et al. Seasonal asthma in northern California: allergic causes and efficacy of immunotherapy. , 1986, The Journal of allergy and clinical immunology.
[102] E. Valovirta,et al. Immunotherapy in allergy to dog. Immunologic and clinical findings of a double-blind study. , 1986, Annals of allergy.
[103] S. Dreborg,et al. Diagnosis and Immunotherapy of Mould Allergy , 1986, Allergy.
[104] B. Björkstén,et al. Oral Immunotherapy of Children with Rhinoconjunctivitis due to Birch Pollen Allergy A Double Blind Study , 1986, Allergy.
[105] G. Hedlin,et al. Immunotherapy with partially purified and standardized animal dander extracts. I. Clinical results from a double-blind study on patients with animal dander asthma. , 1986, The Journal of allergy and clinical immunology.
[106] C. Collins-Williams. Non-allergic bronchial hyperreactivity in asthmatic children decreases with age and increases with mite immunotherapy. , 1986, Annals of allergy.
[107] A. Koivikko,et al. A Double‐Blind, Multicenter Immunotherapy Trial in Children, Using a Purified and Standardized Cladosporium herbarum Preparation I. Clinical Results , 1986, Allergy.
[108] Rocha Em. Effect of 2 therapeutic protocols in minor forms of respiratory allergy , 1986 .
[109] J. Bousquet,et al. Immunotherapy with a standardized Dermatophagoides pteronyssinus extract. I. In vivo and in vitro parameters after a short course of treatment. , 1985, The Journal of allergy and clinical immunology.
[110] R. Djurup,et al. Oral Administration of Grass Pollen to Hay Fever Patients , 1985, Allergy.
[111] Moshkevich Vs. Local immunotherapy for chronic respiratory allergic pathology with allergen aerosols. II. Treatment of bronchial asthma. , 1985 .
[112] A. Murray,et al. Non-allergic bronchial hyperreactivity in asthmatic children decreases with age and increases with mite immunotherapy. , 1985, Annals of allergy.
[113] J. Bousquet,et al. Comparison between rush immunotherapy with a standardized allergen and an alum adjuved pyridine extracted material in grass pollen allergy , 1985, Clinical allergy.
[114] J. Darbyshire,et al. A controlled trial of oral hyposensitization in pollen asthma and rhinitis in children , 1984, Clinical allergy.
[115] G. Pauli,et al. Clinical and immunologic evaluation of tyrosine-adsorbed Dermatophagoides pteronyssinus extract: a double-blind placebo-controlled trial. , 1984, The Journal of allergy and clinical immunology.
[116] S. Findlay,et al. Immunotherapy in cat-induced asthma. Double-blind trial with evaluation of in vivo and in vitro responses. , 1984, The Journal of allergy and clinical immunology.
[117] E. Valovirta,et al. Immunotherapy in allergy to dog: a double-blind clinical study. , 1984, Annals of allergy.
[118] E. Hey,et al. A controlled trial of hyposensitization with adsorbed tyrosine Dermatophagoides pteronyssinus antigen in childhood asthma: in vivo aspects , 1984, Clinical allergy.
[119] E. Hey,et al. In vitro investigations in asthmatic children undergoing hyposensitization with tyrosine‐adsorbed Dermatophagoides pteronyssinus antigen , 1984, Clinical allergy.
[120] T. Haahtela,et al. Hyposensitization in hay fever with grass pollen extracts: a three-year study comparing a dialysed alum adsorbed extract with allpyral. , 1984, Annals of allergy.
[121] E. Pastorello,et al. Grass pollen immunotherapy: a single year double-blind, placebo-controlled study in patients with grass pollen-induced asthma and rhinitis. , 1984, The Journal of allergy and clinical immunology.
[122] R. Patterson,et al. A double-blind histamine placebo-controlled trial of polymerized whole grass for immunotherapy of grass allergy. , 1983, The Journal of allergy and clinical immunology.
[123] B. Weeke,et al. Orally Administered Grass Pollen , 1983, Allergy.
[124] J. Kalbfleisch,et al. Comparison of Rinkel injection therapy with standard immunotherapy. , 1982, The Journal of allergy and clinical immunology.
[125] O. Østerballe. Immunotherapy with Grass Pollen Major Allergens , 1982 .
[126] R. Patterson,et al. A double-blind, placebo-controlled trial of polymerized whole ragweed for immunotherapy of ragweed allergy. , 1982, The Journal of allergy and clinical immunology.
[127] M. Turner,et al. Failure of hyposensitisation in treatment of children with grass-pollen asthma , 1982, British medical journal.
[128] R. Urbanek,et al. [Efficacy of oral hyposensitization treatment in house dust mite allergy (author's transl)]. , 1982, Monatsschrift Kinderheilkunde : Organ der Deutschen Gesellschaft fur Kinderheilkunde.
[129] H. Chai,et al. Efficacy of rush immunotherapy in decreasing bronchial sensitivity to inhaled antigens in perennial childhood asthma. , 1981, Annals of allergy.
[130] Wu Th,et al. Treatment of asthmatic patients sensitive to mites (Dermatophagoides farinae); a four-year study of immunotherapy with an extract of Dermatophagoides farinae. , 1981 .
[131] G. Pauli,et al. Grass Pollen Hyposensitization versus Placebo Therapy , 1981, Allergy.
[132] M. Reinert,et al. [Hyposensitization with tyrosine-allergoids (author's transl)]. , 1981, Praxis und Klinik der Pneumologie.
[133] P. Choovoravech. Effect of immunotherapy: treatment with mite and other aeroallergens in Thai allergic patients. , 1980, Journal of the Medical Association of Thailand = Chotmaihet thangphaet.
[134] U. Wahn,et al. Efficacy and specificity of immunotherapy with laboratory animal allergen extracts. , 1980, The Journal of allergy and clinical immunology.
[135] B. Wüthrich,et al. [Pollinosis. II. Specific hyposensitization: indications and results of treatment. A study with the allergen preparation Stallergenes-Depot in the pollen season of 1976, 1977 and 1978]. , 1980, Schweizerische medizinische Wochenschrift.
[136] A. MartorellAragonés,et al. [Bronchial asthma. Clinical evolution with hyposensitization (author's transl)]. , 1980 .
[137] A. Sychłowy,et al. [Treatment of asthma caused by house-dust mites with a combination of intal and vaccine adsorbed on tyrosine]. , 1979, Pediatria polska.
[138] S. Ahlstedt,et al. Immunotherapy in Spring‐Time Hay Fever , 1979, Allergy.
[139] A. Szczeklik,et al. [Multicenter controlled trial of desensitization treatment of pollen-induced hay fever and asthma with pollinex vaccine]. , 1979, Polski tygodnik lekarski.
[140] M. Götz,et al. [Immunotherapy of allergic disease. Studies on 460 patients]. , 1979, Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete.
[141] A. Swatko,et al. [Evaluation of the effectiveness of desensitization in bronchial asthma caused by house dust mites or grass pollen in the light of clinical results and the histamine and polymyxin inhalation test]. , 1979, Polski tygodnik lekarski.
[142] Kozhem'iaka Ai,et al. Effectiveness of the specific hyposensitization of children with allergoses using a peroral vaccine from house dust , 1979 .
[143] E. Hey,et al. CONTROLLED TRIAL OF HYPOSENSITISATION TO DERMATOPHAGOIDES PTERONYSSINUS IN CHILDREN WITH ASTHMA , 1978, The Lancet.
[144] L. Lichtenstein,et al. The clinical and immunologic specificity of immunotherapy. , 1978, The Journal of allergy and clinical immunology.
[145] R. Avila,et al. Results of a clinical trial with a Dermatophagoides pteronyssinus tyrosine adsorbed vaccine. , 1978, Allergologia et immunopathologia.
[146] F. C. Lowell,et al. Immunotherapy in cat-induced asthma. Double-blind trial with evaluation of bronchial responses to cat allergen and histamine. , 1978, The Journal of allergy and clinical immunology.
[147] L. Lichtenstein,et al. The role of ragweed pollen in autumnal asthma. , 1977, The Journal of allergy and clinical immunology.
[148] J. Warner,et al. Hyposensitisation with house dust mite vaccine in bronchial asthma. , 1976, British medical journal.
[149] H. Pence,et al. Immunotherapy for mountain cedar pollinosis. A double-blind controlled study. , 1976, The Journal of allergy and clinical immunology.
[150] D. Munro-Ashman,et al. Treatment of allergy to house dust with pyridine-extracted alum-precipitated extracts of the house dust mite. , 1976, Annals of allergy.
[151] P. Choovoravech. Effect of immunotherapy in bronchial asthma: treatment with extracts of house dust and mite. , 1974, Journal of the Medical Association of Thailand = Chotmaihet thangphaet.
[152] A. P. Norman,et al. A double blind controlled trial of house mite fortified house dust vaccine in childhood asthma , 1974, Clinical allergy.
[153] V. Aa,et al. Letter: Nutritional muscular dystrophy and human myocardial infarction. , 1973 .
[154] M. Megson,et al. Hyposensitization with Dermatophagoides pteronyssinus in house dust allergy: a controlled study of clinical and immunological effects , 1973, Clinical allergy.
[155] B. Wüthrich,et al. [Peroral desensitization of inhalation allergies in childhood: treatment results]. , 1973, Schweizerische medizinische Wochenschrift.
[156] M. Tuchinda,et al. Effect of immunotherapy in chronic asthmatic children. , 1973, The Journal of allergy and clinical immunology.
[157] J. Meade,et al. Correlation of type specific fluorescent antibodies to ragweed with symptomatology: double-blind study. , 1972, Annals of allergy.
[158] L. Lichtenstein,et al. A single year of immunotherapy for ragweed hay fever. Immunologic and clinical studies. , 1971, Annals of internal medicine.
[159] A. Smith,et al. Hyposensitization with Dermatophagoides pteronyssinus Antigen: Trial in Asthma Induced by House Dust , 1971, British medical journal.
[160] B. Wüthrich,et al. [Specific therapy of pollinosis. Results of desensitization with two different semi-depot allergen extracts (Allpyral and Suspal)]. , 1971, Schweizerische medizinische Wochenschrift.
[161] K. Maunsell,et al. Hyposensitisation in mite asthma. , 1971, Lancet.
[162] K. Aas. HYPOSENSITIZATION IN HOUSE DUST ALLERGY ASTHMA , 1971, Acta paediatrica Scandinavica.
[163] B. Lewis. Points from Letters: Race and Commonwealth , 1970 .
[164] Vooren Ph. Double blind desensitization in asthma , 1969 .
[165] Taub Sj. Ragweed hayfever and asthma. , 1969 .
[166] E. Mellits,et al. Immunotherapy of pollinosis in children: investigation of the immunologic basis of clinical improvement. , 1969, The New England journal of medicine.
[167] D. Johnstone,et al. The value of hyposensitization therapy for bronchial asthma in children--a 14-year study. , 1968, Pediatrics.
[168] P. Heaf,et al. Depot grass-pollen injections in asthma: effect of repeated treatment on clinical response and measured bronchial sensitivity. , 1967, British medical journal.
[169] S. Sanders. The treatment of seasonal hay fever and asthma in children. A controlled trial of pre-seasonal depot pollen therapy. , 1966, The Practitioner.
[170] W. Tattersall,et al. BRITISH Tuberculosis Association. , 1965, Tubercle.
[171] R. Weston,et al. SELF-TEACHING IN HOSPITAL. , 1965, Lancet.
[172] G. J. Cunningham,et al. VENTILATION OF OPERATING-THEATRES. , 1964, Lancet.
[173] D. Johnstone,et al. Value of hyposensitization therapy for perennial bronchial asthma in children. , 1961, Pediatrics.
[174] S. J. Levin. Hyposensitizing (Immunizing) Inoculations in Hay Fever and Asthma , 1959 .
[175] D. E. Johnstone. Study of the role of antigen dosage in the treatment of pollenosis and pollen asthma. , 1957, A.M.A. journal of diseases of children.
[176] S. Kraepelien,et al. Specific Desensitization in Bronchial Asthma in Childhood , 1957, Acta paediatrica.
[177] D. Gairdner. The Integration of Medicine , 1955 .
[178] O. Swineford,et al. Treatment of pollen hay fever and asthma with aerosols of pollen extracts. , 1955, The Journal of allergy.
[179] A. Frankland,et al. Prophylaxis of summer hay-fever and asthma: a controlled trial comparing crude grass-pollen extracts with the isolated main protein component. , 1954, Lancet.
[180] A. Unger,et al. Treatment of bronchial asthma. , 1952, Journal of the American Medical Association.
[181] E. Bruun. CONTROL EXAMINATION OF THE SPECIFICITY OF SPECIFIC DESENSITIZATION IN ASTHMA , 1949, Acta allergologica.
[182] Hisashi Matsubara,et al. Study of specific IgE and IgG4 antibodies to mite antigen in asthmatic children during immunotherapy , 1998 .
[183] M. Abramson,et al. Ragweed immunotherapy in adult asthma. , 1996, The New England journal of medicine.
[184] E. Valovirta,et al. 198 Immunotherapy as preventive allergy treatment (PAT) , 1996 .
[185] H. Nelson,et al. Safety and efficacy of oral immunotherapy with standardized cat extract. , 1994, The Journal of allergy and clinical immunology.
[186] R. Ariano,et al. Local Immunotherapy of Seasonal Allergic Rhinitis in Children Due to Parietaria officinalis Pollen: A Preliminary Report , 1993 .
[187] S. Mills. The development of the complementary medical professions , 1993 .
[188] P. Sánchez Guijo,et al. Monitoring of various types of immunotherapy with gramineal pollens. I. Variation of clinical and biochemical parameters. , 1992, Allergologia et immunopathologia.
[189] H. Malling. Diagnosis and immunotherapy of mould allergy. With special reference to Cladosporium herbarum. , 1990, Danish medical bulletin.
[190] X. Leng,et al. A double-blind trial of oral immunotherapy for Artemisia pollen asthma with evaluation of bronchial response to the pollen allergen and serum-specific IgE antibody. , 1990, Annals of allergy.
[191] G. Hedlin,et al. Immunotherapy with cat- and dog-dander extracts. IV. Effects of 2 years of treatment. , 1989, The Journal of allergy and clinical immunology.
[192] A. Sánchez Palacios,et al. Comparative clinical-immunological study of oral and subcutaneous immunotherapy in children with extrinsic bronchial asthma. , 1989, Allergologia et immunopathologia.
[193] B. Kang,et al. The role of immunotherapy in cockroach asthma. , 1988, The Journal of asthma : official journal of the Association for the Care of Asthma.
[194] E. M. Rocha. [Effect of 2 therapeutic protocols in minor forms of respiratory allergy]. , 1986, Allergie et immunologie.
[195] V. S. Moshkevich. Local immunotherapy for chronic respiratory allergic pathology with allergen aerosols. II. Treatment of bronchial asthma. , 1985, Allergologia et immunopathologia.
[196] H. Richerson,et al. 121 Modification of late asthmatic responses (LAR) during immunotherapy for Alternaria -induced asthma , 1983 .
[197] T. Wun,et al. Treatment of asthmatic patients sensitive to mites (Dermatophagoides farinae); a four-year study of immunotherapy with an extract of Dermatophagoides farinae. , 1981, Annals of allergy.
[198] F. Muñoz-López. Immunotherapy--methods of treatment and results in children. , 1981, Allergologia et immunopathologia.
[199] D. J. Buchanan,et al. A double blind controlled trial of Bencard house dust mite (Migen) hyposensitisation in Zambian asthmatics. , 1980, Medical journal of Zambia.
[200] A. I. Kozhem'iaka,et al. [Effectiveness of the specific hyposensitization of children with allergoses using a peroral vaccine from house dust]. , 1979, Pediatriia akusherstvo i ginekologiia.
[201] D. Newton,et al. House dust mite hyposensitization. , 1978, British journal of diseases of the chest.
[202] P. Choovoravech,et al. Effect of immunotherapy in bronchial asthma: treatment with mite extract absorbed on tyrosine. , 1976, Current medical research and opinion.
[203] P. Vooren. [Double blind desensitization in asthma]. , 1969, Nederlands tijdschrift voor geneeskunde.